Arcutis Biotherapeutics Inc’s recently made public that its insider Matsuda Masaru unloaded Company’s shares for reported $24807.0 on May 28 ’25. In the deal valued at $13.78 per share,1,800 shares were sold. As a result of this transaction, Matsuda Masaru now holds 202,599 shares worth roughly $2.73 million.
Then, Matsuda Masaru bought 1,800 shares, generating $24,807 in total proceeds.
Before that, Heron Patrick J bought 2,520 shares. Arcutis Biotherapeutics Inc shares valued at $34,423 were divested by the Director at a price of $13.66 per share. As a result of the transaction, Heron Patrick J now holds 20,014 shares, worth roughly $0.27 million.
H.C. Wainwright initiated its Arcutis Biotherapeutics Inc [ARQT] rating to a Buy in a research note published on December 30, 2024; the price target was $19. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. Mizuho also remained covering ARQT and has increased its forecast on January 03, 2024 with a “Buy” recommendation from previously “Neutral” rating. Mizuho revised its rating on October 26, 2023. It rated ARQT as “a Neutral” which previously was an “a Buy”.
Price Performance Review of ARQT
On Monday, Arcutis Biotherapeutics Inc [NASDAQ:ARQT] saw its stock jump 3.37% to $13.48. Over the last five days, the stock has lost -3.58%. Arcutis Biotherapeutics Inc shares have fallen nearly -3.23% since the year began. Nevertheless, the stocks have risen 56.93% over the past one year. While a 52-week high of $17.75 was reached on 03/25/25, a 52-week low of $6.99 was recorded on 02/11/25. SMA at 50 days reached $14.44, while 200 days put it at $12.40.
Levels Of Support And Resistance For ARQT Stock
The 24-hour chart illustrates a support level at 13.18, which if violated will result in even more drops to 12.89. On the upside, there is a resistance level at 13.71. A further resistance level may holdings at 13.95. The Relative Strength Index (RSI) on the 14-day chart is 45.21, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.43, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.15%. Stochastics %K at 25.76% indicates the stock is a holding.
